Recursion Pharmaceuticals, Inc. (RXRX)

3.34 -0.10 (-2.91%) USD  |  NASDAQ  |  Aug 28, 16:00
3.33 -0.01 (-0.30%) Pre-Market: 20:00
More

Recursion Pharmaceuticals EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for RXRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical EPS Diluted (5 Year Growth) Data

View and export this data back to 2024. Start Trial.
Date Value
December 31, 2025 --
Date Value
December 31, 2024 --

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Twist Bioscience Corp. Upgrade
Absci Corp. Upgrade
Novavax, Inc. Upgrade
Editas Medicine, Inc. Upgrade
Halozyme Therapeutics, Inc. Upgrade